GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS)
CNY 13.79
(0.07%)
CNY 13.79
(0.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.61 Billion | 1.2 Billion | 938.96 Million | 630.22 Million | 883.78 Million | 722.34 Million |
| Cost of Revenue | 459.64 Million | 339.5 Million | 277 Million | 208.97 Million | 298.75 Million | 249.77 Million |
| Gross Profit | 1.15 Billion | 861.81 Million | 661.95 Million | 421.24 Million | 585.02 Million | 472.57 Million |
| Operating Expenses | 861.16 Million | 637.81 Million | 498.93 Million | 313.25 Million | 430.24 Million | 373.09 Million |
| Selling, General and Administrative Expenses | 882.55 Million | 583.32 Million | 466.97 Million | 286.7 Million | 400.51 Million | 345.68 Million |
| Research and Development Expenses | 30.61 Million | 17.86 Million | 7.68 Million | 5.63 Million | 3.51 Million | 6.86 Million |
| Other Expenses | -52 Million | 36.62 Million | 24.28 Million | 20.91 Million | 26.22 Million | 30.36 Million |
| Cost and Expenses | 1.29 Billion | 977.31 Million | 775.94 Million | 522.22 Million | 729 Million | 622.87 Million |
| Operating Income | 335.82 Million | 225.54 Million | 179.19 Million | 112.27 Million | 154.59 Million | 99.77 Million |
| Interest Expense | 4.16 Million | 5.24 Million | 8.33 Million | 2.19 Million | 163.77 Thousand | 273.45 Thousand |
| Income Tax Expense | 39.15 Million | 30.62 Million | 28.04 Million | 15.94 Million | 22.72 Million | 19.65 Million |
| Earnings before Tax | 334.02 Million | 222.55 Million | 176.65 Million | 109.89 Million | 155.79 Million | 130.13 Million |
| Net Income | 292.7 Million | 201.28 Million | 152.28 Million | 93.95 Million | 133.08 Million | 110.48 Million |
| Earnings Per Share Basic | 0.72 | 0.49 | 0.37 | 0.23 | 0.33 | 0.30 |
| Earnings Per Share Diluted | 0.72 | 0.49 | 0.37 | 0.23 | 0.33 | 0.30 |
| Weighted Average Shares Outstanding | 406.78 Million | 407.32 Million | 407.32 Million | 407.32 Million | 407.32 Million | 366.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 406.78 Million | 407.32 Million | 407.32 Million | 407.32 Million | 407.32 Million | 368.27 Million |
| Gross Margin | 0.72 | 0.72 | 0.70 | 0.67 | 0.66 | 0.65 |
| EBIT Margin | 0.23 | 0.21 | 0.21 | 0.19 | 0.19 | 0.19 |
| Profit Margin | 0.18 | 0.17 | 0.16 | 0.15 | 0.15 | 0.15 |
| EBITDA | 369.18 Million | 243.99 Million | 191.58 Million | 112.97 Million | 159.72 Million | 138.02 Million |
| Earnings Before Tax Margin | 0.21 | 0.19 | 0.19 | 0.18 | 0.17 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 526.88 Million | 492.49 Million | 417.42 Million | 1.61 Billion | 658.94 Million | 338.84 Million |
| Cost of Revenue | 153.65 Million | 170.02 Million | 128.67 Million | 459.64 Million | 186.66 Million | 82.66 Million |
| Gross Profit | 373.22 Million | 322.46 Million | 288.74 Million | 1.15 Billion | 472.27 Million | 256.18 Million |
| Operating Expenses | 275.6 Million | 253.74 Million | 215.63 Million | 889.3 Million | 372 Million | 191.7 Million |
| Selling, General and Administrative Expenses | 383.67 Million | 243.82 Million | 206.98 Million | - | 358.18 Million | 203.74 Million |
| Research and Development Expenses | 12.42 Million | 8.52 Million | 8.89 Million | - | 12.13 Million | 8.05 Million |
| Other Expenses | -120.49 Million | -1.39 Million | 247.39 Thousand | -1.38 Million | -1.67 Million | -1.03 Million |
| Cost and Expenses | 429.26 Million | 423.76 Million | 344.3 Million | 1.34 Billion | 558.67 Million | 274.36 Million |
| Operating Income | 93.24 Million | 68.72 Million | 73.11 Million | 269.43 Million | 100.26 Million | 66.05 Million |
| Interest Expense | - | 4.46 Million | 5.77 Million | 4.13 Million | 349.79 Thousand | 2.23 Million |
| Income Tax Expense | 13.57 Million | 10.19 Million | 10.71 Million | 39.15 Million | 14.47 Million | 7.72 Million |
| Earnings before Tax | 93.89 Million | 71.79 Million | 67.65 Million | 327.42 Million | 150.74 Million | 65.01 Million |
| Net Income | 77.07 Million | 61.01 Million | 56.04 Million | 292.7 Million | 134.73 Million | 57.01 Million |
| Earnings Per Share Basic | 0.19 | 0.15 | 0.14 | - | 0.33 | 0.14 |
| Earnings Per Share Diluted | 0.19 | 0.15 | 0.14 | - | 0.33 | 0.14 |
| Weighted Average Shares Outstanding | 406.78 Million | 406.84 Million | 406.78 Million | 406.78 Million | 406.78 Million | 408.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 406.78 Million | 406.84 Million | 406.78 Million | 406.78 Million | 406.78 Million | 408.33 Million |
| Gross Margin | 0.71 | 0.65 | 0.69 | 0.72 | 0.72 | 0.76 |
| EBIT Margin | 0.18 | 0.18 | 0.18 | - | 0.17 | 0.20 |
| Profit Margin | 0.15 | 0.12 | 0.13 | 0.18 | 0.20 | 0.17 |
| EBITDA | 93.6 Million | 87.78 Million | 73.37 Million | - | 110.95 Million | 67.9 Million |
| Earnings Before Tax Margin | 0.18 | 0.14 | 0.18 | 0.17 | 0.15 | 0.19 |
PANABYTE
HEIQ
601233
DUN
HASTIFIN
002841